Recursion's $316M Trading Volume Surge Propels It to 263rd in Daily Rankings

On June 6, 2025, Recursion's trading volume reached $316 million, marking a significant increase of 103.76% compared to the previous day. This surge placed Recursion at the 263rd position in the daily stock market rankings. The company's stock price also saw a notable rise of 20.13%.

Recursion, in collaboration with MIT, has introduced Boltz-2, a groundbreaking AI model designed to predict molecular binding affinity with unprecedented speed and accuracy. This next-generation model is powered by Recursion's NVIDIA supercomputer, which facilitates its training and validation processes. Boltz-2 achieves best-in-class accuracy in jointly modeling structure and binding affinity, setting a new standard in virtual screening capabilities. The model is now open-sourced for both academic and commercial use, allowing for broader applications in drug discovery and development.

Boltz-2's capabilities include delivering accurate binding calculations at a speed 1,000 times faster than previous models. This advancement is expected to significantly enhance the efficiency and effectiveness of drug discovery processes, potentially leading to faster development of new therapeutics. The open-source nature of Boltz-2 ensures that researchers and developers worldwide can leverage its capabilities, fostering innovation and collaboration in the field of biomolecular research.